Derek Hicks - Net Worth and Insider Trading

Derek Hicks Net Worth

The estimated net worth of Derek Hicks is at least $767,850 dollars as of 2024-04-28. Derek Hicks is the EVP, Chief Business Officer of Intellia Therapeutics Inc and owns about 36,987 shares of Intellia Therapeutics Inc (NTLA) stock worth over $767,850. Details can be seen in Derek Hicks's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Derek Hicks has not made any transactions after 2024-01-03 and currently still holds the listed stock(s).

Transaction Summary of Derek Hicks

To

Derek Hicks Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Derek Hicks owns 1 companies in total, including Intellia Therapeutics Inc (NTLA) .

Click here to see the complete history of Derek Hicks’s form 4 insider trades.

Insider Ownership Summary of Derek Hicks

Ticker Comapny Transaction Date Type of Owner
NTLA Intellia Therapeutics Inc 2024-01-03 EVP & Chief Business Officer

Derek Hicks Latest Holdings Summary

Derek Hicks currently owns a total of 1 stock. Derek Hicks owns 36,987 shares of Intellia Therapeutics Inc (NTLA) as of January 3, 2024, with a value of $767,850.

Latest Holdings of Derek Hicks

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NTLA Intellia Therapeutics Inc 2024-01-03 36,987 20.76 767,850

Holding Weightings of Derek Hicks


Derek Hicks Form 4 Trading Tracker

According to the SEC Form 4 filings, Derek Hicks has made a total of 2 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Intellia Therapeutics Inc is the sale of 3,877 shares on January 3, 2024, which brought Derek Hicks around $114,216.

Insider Trading History of Derek Hicks

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Derek Hicks Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Derek Hicks Ownership Network

Ownership Network List of Derek Hicks

No Data

Ownership Network Relation of Derek Hicks


Derek Hicks Owned Company Details

What does Intellia Therapeutics Inc do?

Who are the key executives at Intellia Therapeutics Inc?

Derek Hicks is the EVP & Chief Business Officer of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Scientific Officer Laura Sepp-lorenzino , EVP & Chief Technical Officer Eliana Clark , and director & President and CEO John M. Leonard .

Intellia Therapeutics Inc (NTLA) Insider Trades Summary

Over the past 18 months, Derek Hicks made 2 insider transaction in Intellia Therapeutics Inc (NTLA) with a net sale of 5,689. Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 11,996 shares made by Eliana Clark , a net sale of 12,645 shares made by Laura Sepp-lorenzino , and a net sale of 2,397 shares made by Muna Bhanji .

In summary, during the past 3 months, insiders sold 0 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 79,775 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 79,775 shares.

Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Intellia Therapeutics Inc Insider Transactions

No Available Data

Derek Hicks Mailing Address

Above is the net worth, insider trading, and ownership report for Derek Hicks. You might contact Derek Hicks via mailing address: C/o Intellia Therapeutics, Inc., 40 Erie Street Suite 130, Cambridge Ma 02139.

Discussions on Derek Hicks

No discussions yet.